Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Short-term Investments (2021 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Short-term Investments for 5 consecutive years, with $241000.0 as the latest value for Q3 2025.

  • Quarterly Short-term Investments fell 50.82% to $241000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $241000.0 through Sep 2025, down 50.82% year-over-year, with the annual reading at $22000.0 for FY2024, 89.42% down from the prior year.
  • Short-term Investments for Q3 2025 was $241000.0 at Xtant Medical Holdings, up from $114000.0 in the prior quarter.
  • The five-year high for Short-term Investments was $490000.0 in Q3 2024, with the low at $22000.0 in Q4 2024.
  • Average Short-term Investments over 5 years is $222500.0, with a median of $212000.0 recorded in 2021.
  • Peak annual rise in Short-term Investments hit 476.47% in 2024, while the deepest fall reached 89.42% in 2024.
  • Over 5 years, Short-term Investments stood at $144000.0 in 2021, then skyrocketed by 45.14% to $209000.0 in 2022, then decreased by 0.48% to $208000.0 in 2023, then crashed by 89.42% to $22000.0 in 2024, then surged by 995.45% to $241000.0 in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $241000.0, $114000.0, and $403000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.